Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1995-11-30
1996-11-19
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514725, A61K 3120, A61K 3107
Patent
active
055763499
ABSTRACT:
Disclosed is a method for terminating an existing potentially lethal cardiac arrhythmia, or preventing an imminent potentially lethal cardiac arrhythmia. The method involves administration of all-trans-retinoic acid or an antiarrhythmically active analog. Antiarrhythmic effects of all-trans-retinoic acid occur within minutes.
REFERENCES:
patent: 4678808 (1987-07-01), Ward et al.
patent: 5310554 (1994-05-01), Haigh
Airaksinen et al., "Association between Silent Coronary Artery Disease, Diabetes, and Autonomic Neuropathy. Fact or Fallacy?" Diabetes Care (1992) 15:288-292.
Aronow, "Prevalence of Presenting Symptoms of Recognized Acute Myocardial Infarction and of Unrecognized Healed Myocardial Infarction in Elderly Patients," Am. J. Cardiol. (1987) 60:1182.
Billman, "Effect of Calcium Channel Antagonists on Cocaine-Induced Malignant Arrhytmias: Protection against Ventricular Fibrillation," J. Pharm. and Exp. Ther. 266:407-416 (1993).
Billman, "Effect of Calcium Channel Antagonists on Suceptibility to Sudden Cardiac Death: Protection from Ventricular Fibrillation," J. Pharm. Expt. Therap. (1989) 248:1334-1342.
Billman et al., "Elevated Myocardial Calcium and its Role in Sudden Cardiac Death," FASB 5:2586-92 (1991).
Billman, "Ro 40-5967, a Novel Calcium Channel Antagonist, Protects Against Ventricular Fibrillation," Eur. J. Pharmacol. (1992) 229:179-187.
Billman, "The Calcium Channel Antagonist, Flunarizine, Protects Against Ventricular Fibrillation," Eur. J. Pharmacol. (1992) 212:231-235.
Hallaq et al., "Protective effect of eicosapentaenoic acid on ouabain toxicity in neonatal rat cardiac myocytes," Proc. Natl. Acad. Sci. USA (1990) 87:7834-7838.
Hallaq et al., "Modulation of Dihydropyridine-sensitive Calcium Channels in Heart Cells by Fish Oil Fatty Cells," Proc. Natl. Acad. Sci. USA (1992) 89(5):1760-1764
Juan et al., "Effect of exogenous 5, 8, 11, 14, 17-eicosapentaenoic acid on cardiac anaphylaxis," Br. J. Pharmac. (1987) 90:315-325.
Kamp et al., "pH gradients across phospholipid membranes caused by fast flip-flop of un-ionized fatty acids," Proc. Natl. Acad. Sci. USA 89:11367-11370 (1992).
Kang et al., "Free long-chain, polyunsaturated fatty acids reduce membrane electrical excitability in neonatal rat cardiac myocytes," Proc. Natl. Acad. Sci. USA 92:3997-4001 (1995).
Kang et al., "Effects of long-chain polyunsaturated fatty acids on the contraction of neonatal rat cardiac myocytes," Proc. Natl. Acad. Sci. USA 91:9886-9890 (1994).
Leaf et al., "Cardiovascular Effects of n-3 Fatty Acids," New England Journal of Medicine (1988) 318:549-557.
Leaf, "Cardiovascular Effects of Fish Oils: Beyond the Platelet," Circulation (1990) 82:624-628.
McLennan et al., "Dietary Fish Oil Prevents Ventricular Fibrillation Following Coronary Artery Occlusion and Reperfusion," American Heart Journal (1988) 116:709-717.
McLennan et al., "Influence of Dietary Lipids on Arrhythmias and Infarction after Coronary Artery Ligation in Rats," Can. J. Physiol. Pharmacol. (1985) 63:1411-1417.
Makita et al., "Successful Management of Life-Threatening Ventricular Arrhythmias with Propafenone in a Hemodialysis Patient," Current Therapeutic Research (1991) 49:954-960.
Steen et al., "Myocardial Reinfarction After Anesthesia and Surgery," JAMA (1978) 239(24):2566-2570.
Xiao et al., "Blocking effects of polyunsaturated fatty acids in Na+ channels of neonatal rat ventricular myocytes," Proc. Nat. Acad. Sci.., 92:1000-11004 (1995).
Yamashita et al., "Effect of Eicosapentaenoic and Docosahexaenoic Acid on Natural Killer Cell Activity in Human Peripheral Blood Lymphocytes," Clinical Immunology and Imunopathology (1991) 59:335-345.
Yamazaki et al., "Changes in fatty acid composition in rat blood and organs after infusion of docosahexaenoic acid ethyl ester.sup.1-3," Am. J. Clin. Nutr. (1991) 53:620-627.
Kang Jing X.
Leaf Alexander
Henley III Raymond
The General Hospital Corporation
LandOfFree
Retionoic acid treatment of cardiac arrhythmia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Retionoic acid treatment of cardiac arrhythmia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Retionoic acid treatment of cardiac arrhythmia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-541419